Nicholas Vitanza, Neuro-oncologist and Scientific Director of the Brain Tumor Program at Seattle Children’s, shared on LinkedIn:
“In med school I never expected to apply for an R01 – much less have one score well enough to be converted to an R37 MERIT award. Thanks to my family, colleagues, the NIH, and Seattle Children’s for al l your support. Let’s End DIPG.”
